Latest Features & Opinion
INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
A collection of news, case studies, and feature articles focused on the diagnosis and management of infection processes in patients with immune systems impaired by an underlying disease.
Clostridium difficile is the most common cause of healthcare-associated infections, with as many as 500,000 cases occurring annually in the United States. Efforts to prevent transmission within hospitals typically focus on patients with symptomatic Clostridium difficile infection.
There is an opportunity to improve HCV treatment rates for people who inject drugs by integrating DAA therapy into current models of community-based addiction.
Clinicians should be aware of the possibility of HIV-2 infection in their patients coming from endemic areas, especially West Africa.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Topical Antibacterial Agent Effective for Treatment of Impetigo
- Novel H pylori Eradication Therapy Effective in Phase 3 Trial
- Polymyxin B Hemoperfusion Does Not Change Mortality Rate in Septic Shock
- Addiction Medicine Consultation Improves Antibiotic Compliance in Patients with Opioid Use Disorders
- Guideline Adoption for Childhood Community-Acquired Pneumonia
- Influenza Point-of-Care Tests Influence Patient Outcomes
- Isavuconazole Not Noninferior to Caspofungin for Invasive Candida Infections
- Lack of Pediatric Preventive Care Ups Unplanned Hospital Admissions
- Pregnant Women Commonly Refuse Vaccines
- High Sensitivity, Specificity for Chlamydia Point-of-Care Test